3D-SHAPER
Turning DXA imaging into 3D patient-specific models for bone disease diagnostics
Company profile
Company profile
Galgo Medical SL is a Barcelona-based medical imaging software company incorporated in July 2013, emerging from the Department of Information Technologies (DTIC) of the Universitat Pompeu Fabra in Barcelona, Spain. The company specializes in developing advanced imaging post-processing software solutions across three primary medical disciplines: stereotactic neurosurgery, cardiac electrophysiology, and osteoporosis diagnostics. In stereotactic neurosurgery, Galgo facilitates multidisciplinary decision-making and planning of stereotactic neurosurgical interventions. For cardiac electrophysiology, the company helps qualified healthcare professionals visualize fibrosis, wall thickness, and surrounding anatomical structures through its spin-off company Adas3D Medical. In osteoporosis diagnostics, Galgo improves bone disease diagnostics by converting DXA imaging into 3D patient-specific models through its spin-off company 3D-SHAPER Medical. The team developed solid experience in imaging post-processing software solutions during more than seven years working together at Universitat Pompeu Fabra, participating in national and international competitive projects while nurturing close collaborations with several clinical institutions. The company has successfully spun off specialized entities to focus on specific clinical applications, demonstrating its innovation in medical imaging technology and its commitment to advancing personalized medicine across multiple therapeutic areas.
Company description Galgo Medical S.L official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Other deployment with recorded integration context.
Company milestones
Participated in multiple Horizon2020 and national research projects (2020-2021) including DIDIMO for personalized cardiac digital twins and DISc4ALL European Training Network. Developed spin-off companies Adas3D Medical and 3D-SHAPER Medical for specialized applications.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Turning DXA imaging into 3D patient-specific models for bone disease diagnostics
Visualization of fibrosis, wall thickness and surrounding anatomical structures
Multidisciplinary decision-making and planning for stereotactic neurosurgical interventions
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
International journal of computer assisted radiology and surgery · Oct 1, 2024
Simulation of intra-saccular devices for pre-operative device size selection: Method and validation for sizing and porosity simulation.Computers in biology and medicine · Aug 1, 2022
Intra-saccular device modeling for treatment planning of intracranial aneurysms: from morphology to hemodynamics.International journal of computer assisted radiology and surgery · Oct 1, 2021
Cerebral Aneurysm Occlusion at 12-Month Follow-Up After Flow-Diverter Treatment: Statistical Modeling for V&V With Real-World Data.Frontiers in medical technology · Jan 1, 2021
Computational anatomy for multi-organ analysis in medical imaging: A review.Medical image analysis · Aug 1, 2019
Computation of the change in length of a braided device when deployed in realistic vessel models.International journal of computer assisted radiology and surgery · Oct 1, 2015
Clinical validation
No linked records are currently available.
Regulatory
K191125 · 510k · Jan 15, 2020
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Converting DXA imaging into 3D patient-specific models for osteoporosis
Fibrosis, wall thickness and surrounding anatomical structures for cardiac procedures
Planning of stereotactic neurosurgical interventions
05 · Leadership
Leadership profiles and professional links from the current Company record.
Antoni Riu
CEO
Luis Serra
President of the Board
Ignacio Delgado
Chief Scientific Officer
Xavi Planes
CTO
Ludovic Humbert
CEO
Jacobo Gil de Biedma
Chief Regulatory Officer
Rosa Maria Figueras
Chief Commercial Officer
Francia Rojas
Quality and Regulatory Manager
06 · Company updates
Recent articles published on Galgo Medical S.L's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.